You are here: Industry Insights > COVID-19

News List

UK pledges £210m to CEPI for Covid-19 vaccine development pharmaceutical-technology
March 30, 2020
Non-profit the Coalition for Epidemic Preparedness Innovations (CEPI) has received £210m from the UK Government to support efforts to develop a Covid-19 vaccine.
US overtakes China with largest number of coronavirus cases pharmaceutical-technology
March 30, 2020
The US now has more confirmed cases of novel coronavirus (Covid-19) than any other country with 85,996 cases, surpassing China and Italy.
Dynavax teams up with CEPI for Covid-19 vaccine pharmaceutical-technology
March 30, 2020
Dynavax Technologies has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine against Covid-19 infection.
US researchers repurpose blood clots drug for Covid-19 pharmaceutical-technology
March 30, 2020
Researchers at Massachusetts Institute of Technology (MIT) and the University of Colorado at Denver in the US are working on repurposing an existing blood clots drug to help patients at risk of respiratory failure.
US researchers repurpose blood clots drug for Covid-19 pharmaceutical-technology
March 30, 2020
Researchers at Massachusetts Institute of Technology (MIT) and the University of Colorado at Denver in the US are working on repurposing an existing blood clots drug to help patients at risk of respiratory failure.
Bionova Scientific Introduces COVID-19 Support Program contractpharma
March 30, 2020
To make lab capacity available to industry partners impacted by COVID-19 shutdowns.
BGI Genomics Receives EUA for SARS-CoV-2 Test Kit contractpharma
March 30, 2020
Test can return results within three hours and is intended for the qualitative detection of the virus that causes COVID-19 disease.
Berkshire Sterile Manufacturing Fills Novel COVID-19 Treatments contractpharma
March 30, 2020
For patients that develop severe lung problems in response to the coronavirus.
BioDuro to Develop COVID-19 Nanobody Therapeutic contractpharma
March 30, 2020
Specialized COVID-19 team and technology assembled to accelerate discovery of new biologic.
Altasciences Completes Phase I Study in COVID-19 Patients contractpharma
March 30, 2020
Gimsilumab, a monoclonal antibody, is being evaluated in patients with or at risk of developing acute respiratory distress syndrome.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page